RECRUITING

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery

Description

Quality of life data following SBRT for prostate cancer has been obtained in only a small numbers of patients. A prospective study using validated quality of life questionnaires is needed to determine outcomes after treatment with SBRT. Our study will be the first essential step in developing a better evidence base on the comparative risks and benefits of SBRT treatment with regards to quality of life assessment and outcomes.

Study Overview

Study Details

Study overview

Quality of life data following SBRT for prostate cancer has been obtained in only a small numbers of patients. A prospective study using validated quality of life questionnaires is needed to determine outcomes after treatment with SBRT. Our study will be the first essential step in developing a better evidence base on the comparative risks and benefits of SBRT treatment with regards to quality of life assessment and outcomes.

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)

Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

Washington

Georgetown University Hospital, Washington, District of Columbia, United States, 20007

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Histologically confirmed adenocarcinoma of prostate
  • * Signed study-specific consent
  • * Prostate Specific Antigen (PSA) within 60 days of registration
  • * Prior pelvic radiotherapy
  • * Prior radical prostate surgery
  • * Medical or psychiatric illness that would interfere with treatment or follow up
  • * Implanted hardware adjacent to the prostate that would prohibit appropriate treatment planning and/or treatment delivery

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Georgetown University,

Sean P Collins, MD, PhD, PRINCIPAL_INVESTIGATOR, Georgetown University Hospital

Study Record Dates

2025-04